Glycocalyx Therapeutics

Biotechnology Research • Basel, Basel, Switzerland • 1-10 Employees

Company overview

Headquarters	Basel, Basel, Switzerland
NAICS	541714
Founded	2023
Employees	1-10

Key Contact at Glycocalyx Therapeutics

Natalia Rodrigues Mantuano

Co-Founder

About Glycocalyx Therapeutics

A discovery & pre-clinical-stage company and a pioneer in the development of transformative intratumoral pan-cancer therapies that target the tumor microenvironment removing barriers and inducing intratumoral immune architecture for effective full-circle immunotherapy. We focus on the discovery, design and engineering of catalytic immune effector systems.

Glycocalyx Therapeutics revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Glycocalyx Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Glycocalyx Therapeutics has never raised funding before.

Frequently asked questions

Glycocalyx Therapeutics is located in Basel, Basel, CH.

Glycocalyx Therapeutics was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

Glycocalyx Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Glycocalyx Therapeutics

Natalia Rodrigues Mantuano

Co-Founder

4.8

40,000 users